Kimia Biosciences Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Cash & Equivalents	-	2.06	1.48	1.78	2.05	5.87
Trading Asset Securities	-	-	-	0.63	0.6	0.58
Cash & Short-Term Investments	7.11	2.06	1.48	2.41	2.65	6.45
Cash Growth	13.21%	39.63%	-38.73%	-9.20%	-58.87%	-0.62%
Accounts Receivable	-	367.51	275.54	305.9	302.01	417.66
Other Receivables	-	7.5	5.36	5.78	36.69	16.37
Receivables	-	375.01	280.9	311.67	338.7	434.03
Inventory	-	345.83	308.04	482.34	370.18	236.87
Prepaid Expenses	-	2.15	1.32	1.42	3.15	2.62
Other Current Assets	-	27.87	22.35	29.63	16.01	38.45
Total Current Assets	-	752.92	614.08	827.47	730.7	718.41
Property, Plant & Equipment	-	309.02	323.8	341.53	350.82	340.43
Other Intangible Assets	-	0.22	0.41	0.85	1.45	0.95
Long-Term Deferred Tax Assets	-	17.63	57.84	39.69	9.08	-
Long-Term Deferred Charges	-	23.57	-	-	-	-
Other Long-Term Assets	-	8.77	3.54	3.64	2.86	6.9
Total Assets	-	1,112	999.67	1,213	1,095	1,067
Accounts Payable	-	504.89	399.88	465.86	402.06	307.86
Accrued Expenses	-	51.61	57.55	50.93	29.71	25.29
Short-Term Debt	-	196.38	197.91	198.32	148.1	131.27
Current Portion of Long-Term Debt	-	25.58	22.01	22.52	13.6	34.57
Current Portion of Leases	-	1.86	1.21	-	-	-
Current Unearned Revenue	-	37.93	15.03	22.97	16.99	6.14
Other Current Liabilities	-	0	0.79	3.38	7.56	4.36
Total Current Liabilities	-	818.25	694.38	763.98	618.02	509.48
Long-Term Debt	-	167	272.17	361.63	293.33	328.3
Long-Term Leases	-	2.76	1.85	-	-	-
Long-Term Unearned Revenue	-	8.48	13.48	18.48	23.47	28.47
Pension & Post-Retirement Benefits	-	14.15	12.68	12.53	11.21	11.69
Long-Term Deferred Tax Liabilities	-	-	-	-	-	4.38
Other Long-Term Liabilities	-	1.81	1.81	1.92	-	-
Total Liabilities	-	1,012	996.36	1,159	946.03	882.33
Common Stock	-	47.31	47.31	47.31	47.31	47.31
Additional Paid-In Capital	-	60.85	60.85	60.85	60.85	60.85
Retained Earnings	-	-8.5	-104.86	-53.54	40.72	76.2
Total Common Equity	115.85	99.66	3.31	54.63	148.88	184.36
Shareholders' Equity	115.85	99.66	3.31	54.63	148.88	184.36
Total Liabilities & Equity	-	1,112	999.67	1,213	1,095	1,067
Total Debt	360.82	393.58	495.14	582.47	455.03	494.14
Net Cash (Debt)	-353.72	-391.52	-493.67	-580.06	-452.38	-487.69
Net Cash Per Share	-7.47	-8.28	-10.43	-12.26	-9.56	-10.31
Filing Date Shares Outstanding	47.32	47.31	47.31	47.31	47.31	47.31
Total Common Shares Outstanding	47.32	47.31	47.31	47.31	47.31	47.31
Working Capital	-	-65.33	-80.3	63.49	112.68	208.93
Book Value Per Share	2.40	2.11	0.07	1.15	3.15	3.90
Tangible Book Value	76.39	99.44	2.9	53.78	147.44	183.41
Tangible Book Value Per Share	1.58	2.10	0.06	1.14	3.12	3.88
Land	-	4.75	4.75	4.75	4.75	4.75
Buildings	-	61.17	61.17	60	60	51.6
Machinery	-	423.4	401.66	390.95	373.58	285.53
Construction In Progress	-	0.03	5.76	6.06	-	57.7

Source: S&P Global Market Intelligence. Standard template. Financial Sources.